Company Email Format Management

ELGAN Pharma

Biotechnology Medical Problems and Developmental Difficulties That Are Common in Babies Born Very Early. 26 employees

Employees: 26
Contacts: 4
Emails: 4
Phones: 1

elganpharma.com LinkedIn Crunchbase

ELGAN Pharma Overview

Headquarters: Medical Problems and Developmental Difficulties That Are Common in Babies Born Very Early.
Website: elganpharma.com
Industry: Biotechnology
Employees: 26
Funding: 2.5M

Keywords

Neonatology Biotechnology Pharmaceutical Development Pediatrics Retinopathy of Prematurity Gastrointestinal Therapies Preterm infants Vision Impairement Late-Stage Clinical

About ELGAN Pharma

We named our company ELGAN Pharma, as we are dedicated to improving outcome for babies who are Extremely Low Gestational Age Newborns (ELGANs). This means they are born more than 3 months before term. Premature birth is the number one cause of newborn deaths. With improved standard-of-care worldwide, survival rate increases, leading to the need of improving outcome and quality of life. ELGAN Pharma is a neonatology-focused biotechnology company, dedicated to developing safe tailored therapies to address medical problems and developmental difficulties that are common in babies born very early.

ELGAN Pharma Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 1; 25.0% coverage

ELGAN Pharma Org Chart

Sample employees and titles

Name	Title	Location	Contact
Udi Nir	Clinical Study Manager	Israel	Email
Miriam Ben David	Cmc Regulatory Affairs Manager	Israel	Email
Liran Mendel, Msc. לירן מנדל	Medical Statistics Training & Research	Israel	Email
Gil Mor	Director of Cmc and Production at Elgan	Israel	Email Phone